Body-oriented Therapy for Women in SUD Treatment

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT01960036
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
217
1
3
53.9
4

Study Details

Study Description

Brief Summary

The long-term objective of this study is to improve women's substance use disorder (SUD) treatment. The immediate project goal is to test the efficacy of an innovative mind-body intervention, Mindful Awareness in Body-Oriented Therapy (MABT) to reduce substance use relapse among women in SUD treatment.

A novel mind-body approach, MABT combines a hands-on (manual) approach with mind-body psycho-education approaches of interoceptive training and mindfulness to develop somatically-based self-care skills and to facilitate emotion regulation. A three-group, randomized clinical trial using repeated measures, this project will enroll and randomize 225 women to one of three groups, MABT + Treatment-as-usual (TAU) (n=75), TAU only (n=75), and Women's Health Education (WHE) + TAU (to control for time and attention) (n=75). Study conditions will be compared at baseline, post-intervention, and at 6 and 12 month follow-up.

The primary aim is to test the hypothesis that MABT will result in reduced substance use and related health outcomes compared to TAU and to WHE+ TAU at 12 month follow-up. The second aim is to examine hypothesized underlying mechanisms of MABT. Female outpatients in two diverse community treatment facilities, serving racially diverse patients, will be recruited for study participation. This study builds on promising preliminary evidence of MABT feasibility and acceptability in substance use disorder treatment for women, and addresses the need for more clinical research aimed at improving SUD treatment outcomes for women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindful Awareness in Body-oriented Therapy
  • Behavioral: Womens Health Education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
217 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Body-oriented Therapy for Womens Substance Use Disorder Treatment
Actual Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Sep 15, 2017
Actual Study Completion Date :
Jun 30, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Treatment as usual (TAU)

Usual intensive outpatient treatment for substance use disorders

Experimental: Mindful Awareness in Body-oriented Therapy (MABT)

A mind-body intervention to teach interoceptive skills for self-care.

Behavioral: Mindful Awareness in Body-oriented Therapy

Active Comparator: Womens Health Education

A comparative arm to control for time and attention that involves education about the human body relevant to women's health.

Behavioral: Womens Health Education

Outcome Measures

Primary Outcome Measures

  1. Timeline Follow-back Interview (TLFB) [Change from baseline in TLFB assessed at different time points (3,6 and 12 months)]

    Collects self-report substance use information using a calendar method

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    1. female, 2) enrolled in intensive outpatient (IOP) with at least 8 weeks remaining in planned SUD treatment program, 3) agrees to forgo (non-study) manual therapies (e.g.,massage) and mind-body therapies (e.g., mindfulness meditation) for 3 months (baseline to post-test); 4) willing to sign release for access of electronic medical records; 5) fluent in English; and 6) can attend MABT and WHE sessions when offered.
Exclusion Criteria:
  • ) untreated psychotic diagnosis or symptoms, using modules from the MINI International Neuropsychiatric Interview; 2) unwilling or unable to remain in treatment for the duration of the trial (includes planned relocation, pending incarceration, planned surgical procedures, etc.); 3) cognitive impairment, to be assessed with an informed consent quiz, followed by the Mini-Mental Status Exam (MMSE), a common screening tool in SUD treatment studies, if there is demonstrated difficulty comprehending the consent; or 4) currently pregnant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Washington Seattle Washington United States 98195

Sponsors and Collaborators

  • University of Washington
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Cynthia J Price, PhD, MA, University of Washington

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cynthia Price, Research Associate Professor, University of Washington
ClinicalTrials.gov Identifier:
NCT01960036
Other Study ID Numbers:
  • 46102-J
  • R01DA033324
First Posted:
Oct 10, 2013
Last Update Posted:
Oct 12, 2018
Last Verified:
Oct 1, 2018
Keywords provided by Cynthia Price, Research Associate Professor, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2018